PMID: 9174127May 1, 1997Paper

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23)

Clinical & Experimental Metastasis
Mary E MieleD R Welch

Abstract

Metastasis is suppressed more than 95% following microcell-mediated transfer of a single copy of neomycin-tagged human chromosome 6 (neo6) into the human melanoma cell lines C8161 and MelJuSo. Concomitant with metastasis suppression is upregulation of NME1 (Nm23-H1) mRNA and protein expression. The purposes of this study were to determine whether NME1 expression was responsible for metastasis suppression in neo6/melanoma hybrids, and whether genes on chromosome 6 regulate NME1. Using neo6/C8161 cells, transfection of CAT reporter constructs linked to the NME1 promoter failed to consistently induce CAT. Therefore, it does not appear that genes on chromosome 6 directly control transcription of NME1. Transfection and overexpression of NME1 in MelJuSo, under the control of the CMV promoter, resulted in 40-80% inhibition of lung metastasis following i.v. inoculation of 2 x 10(5) cells. Only one transfectant of C8161 subclone 9 (C8161cl.9) cells was suppressed for metastasis. Control transfections with pCMVneo or pSV2neo did not suppress metastasis in either cell line. Taken together, these data suggest that NME1 can reduce metastatic potential of some human melanoma cells; but, this inhibitory activity appears to be independent of t...Continue Reading

Citations

Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·G P RobertsonW K Cavenee
May 6, 2009·Molecular and Cellular Biochemistry·Jong Heun LeeChristine E Horak
Oct 3, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Imran Khan, Patricia S Steeg
Oct 16, 2002·World Journal of Gastroenterology : WJG·Lun-Xiu Qin
Dec 7, 2007·Clinical & Experimental Metastasis·William G McDermottChristine E Horak
Apr 16, 2011·Journal of Surgical Oncology·Chengying LiuWei Wang
Jun 12, 2012·Cancer Metastasis Reviews·Jinchun Yan, Qihong Huang
Nov 14, 2015·Journal of Cellular Biochemistry·Dong-Joo YouJong-Ik Hwang
Jan 2, 2003·Nature Reviews. Cancer·Patricia S Steeg
Sep 1, 2006·Journal of Bioenergetics and Biomembranes·Diane PalmieriPatricia S Steeg
May 5, 2005·Journal of the National Cancer Institute·Diane PalmieriPatricia S Steeg
Jul 10, 2002·The Journal of Biological Chemistry·Melanie T HartsoughPatricia S Steeg
Aug 23, 2012·Journal of the National Cancer Institute·Jean-Claude A MarshallPatricia S Steeg
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David PáezHeinz-Josef Lenz
Aug 2, 2003·Cancer Letters·Lalita A Shevde, Danny R Welch
May 15, 2003·Clinical Breast Cancer·Patricia S SteegMassimiliano Salerno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.